Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
Oxford Immunotec Global PLC (OXFD) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/03/2020 8-K Quarterly results
Docs: " "
08/04/2020 8-K Quarterly results
05/05/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "Oxford Immunotec Reports Third Quarter 2019 Financial Results"
08/06/2019 8-K Quarterly results
Docs: "Oxford Immunotec Reports Second Quarter 2019 Financial Results"
05/09/2019 8-K Quarterly results
Docs: "Oxford Immunotec Reports First Quarter 2019 Financial Results"
03/11/2019 8-K Quarterly results
Docs: "Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results"
11/09/2018 8-K Quarterly results
Docs: "Oxford Immunotec Reports Third Quarter 2018 Financial Results",
"Unaudited Non-GAAP Pro Forma Condensed Combined Statement of Operations"
07/31/2018 8-K Quarterly results
Docs: "Oxford Immunotec Reports Second Quarter 2018 Financial Results"
05/01/2018 8-K Quarterly results
Docs: "Oxford Immunotec Reports First Quarter 2018 Financial Results"
02/27/2018 8-K Quarterly results
Docs: "Oxford Immunotec Reports Fourth Quarter and Full Year 2017 Financial Results"
10/31/2017 8-K Quarterly results
08/01/2017 8-K Quarterly results
Docs: "Three Months Ended June 30, 2017 2016 Percent Change Product $ 10.4 $ 9.3 12 % Service 15.7 9.9 59 % Total Revenue $ 26.1 $ 19.2 36 % By indication, total revenues were, in millions: Three Months Ended June 30, 2017 2016 Percent Change Tuberculosis $ 21.3 $ 19.2 12 % Tick-Borne Disease and Other 4.8 — NM Total Revenue $ 26.1 $ 19.2 36 % By geography, total revenues were, in millions: Three Months Ended June 30, Percent Change 2017 2016 As Reported Constant Currency United States $ 16.1 $ 9.8 65 % 65 % Europe & ROW 1.9 2.0 -2 % 3 % Asia 8.1 7.4 9 % 8 % Total revenue $ 26.1 $ 19.2 36 % 36 % Changes in revenue include the impact of changes in foreign currency exchange rates. We use the non-GAAP financial measure "constant currency basis" in our filings to show changes in our revenue without g..."
05/02/2017 8-K Form 8-K - Current report
11/01/2016 8-K Form 8-K - Current report
08/02/2016 8-K Form 8-K - Current report
05/03/2016 8-K Form 8-K - Current report
11/03/2015 8-K Form 8-K - Current report
08/04/2015 8-K Form 8-K - Current report
05/05/2015 8-K Form 8-K - Current report
11/04/2014 8-K Form 8-K - Current report
08/05/2014 8-K Form 8-K - Current report
05/06/2014 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy